Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -87.72% is 81% below its 5-year average of -48.41%, near the low end of its 5-year range (-100.84%–-14.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.96% above its 12-month average of -93.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -87.72%.
RETURN ON INVESTED CAPITAL (ROIC)
-87.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-93.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-62.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-48.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.96%
CURRENT VS 3Y AVG
-40.29%
CURRENT VS 5Y AVG
-81.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.53%
median of 573 covered companies
CURRENT VS SECTOR MEDIAN
-169.65%
vs the sector median at left
Caribou Biosciences, Inc.
Market Cap
$116.54M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-93.28%
3Y Avg
-62.52%
5Y Avg
-48.41%
Market Cap
$116.57M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$116.83M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
Market Cap
$114.79M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$114.62M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$120.24M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$112.52M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
Market Cap
$112.36M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$121.25M
Return on Invested Capital (ROIC)
-1.78%
TTM Avg
-41.34%
3Y Avg
-32.26%
5Y Avg
-28.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | $116.54M | -87.72% | -93.28% | -62.52% | -48.41% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $116.57M | -223.06% | -221.51% | -125.15% | -99.68% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.83M | -61.84% | -30.30% | -57.06% | -116.42% |
| Genelux Corporation (GNLX)vs › | $114.79M | -192.18% | -186.03% | -161.77% | -220.86% |
| MaxCyte, Inc. (MXCT)vs › | $114.62M | -19.83% | -23.34% | -19.01% | -18.39% |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.24M | -137.40% | -133.78% | -372.93% | -315.43% |
| Lucid Diagnostics Inc. (LUCD)vs › | $112.52M | -145.10% | -158.49% | -239.94% | -201.97% |
| Coya Therapeutics, Inc. (COYA)vs › | $112.36M | -0.05% | -44.27% | -81.25% | -78.53% |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | -1.78% | -41.34% | -32.26% | -28.21% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $110.73M | -34.77% | -10.04% | -11.68% | -11.21% |
ROIC
-87.7%
ROE
-105.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -87.72% |
| 2026-03-31 | -100.84% |
| 2025-12-31 | -95.45% |
| 2025-09-30 | -95.11% |
| 2025-06-30 | -87.29% |
| 2025-03-31 | -66.70% |
| 2024-12-31 | -58.95% |
| 2024-09-30 | -52.91% |
| 2024-06-30 | -41.18% |
| 2024-03-31 | -34.51% |
| 2023-12-31 | -28.73% |
| 2023-09-30 | -25.16% |
| 2023-06-30 | -38.28% |
| 2023-03-31 | -36.30% |
| 2022-12-31 | -30.78% |
| 2022-09-30 | -25.94% |
| 2022-06-30 | -22.45% |
| 2022-03-31 | -18.09% |
| 2021-12-31 | -16.35% |
| 2021-09-30 | -14.42% |
| 2021-06-30 | -39.55% |
| 2021-03-31 | -26.55% |
| 2020-12-31 | -148.60% |
